Protagonist Therapeutics PTGX
$ 46.12
10.72%
Quarterly report 2024-Q3
added 11-07-2024
Protagonist Therapeutics EV/EBITDA Ratio 2011-2024 | PTGX
Annual EV/EBITDA Ratio Protagonist Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-10.1 | -10.7 | -2.14 | -2.36 | -7.54 | -3.13 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-2.14 | -10.7 | -6 |